Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-15 Purchase | 2021-06-17 7:09 pm | PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director | 11,764 | $8.5 | $99,994 | 20,764 (Direct) | View |
| 2021-06-03 Sale | 2021-06-04 7:52 pm | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 9,492 | $21.96 | $208,421 | 122,196 (Direct) | View |
| 2021-06-01 Sale | 2021-06-02 9:47 pm | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 45,119 | $22.1 | $996,963 | 131,688 (Direct) | View |
| 2021-05-06 Sale | 2021-05-07 6:28 pm | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 20,416 | $23.45 | $478,845 | 149,034 (Direct) | View |
| 2021-05-03 Sale | 2021-05-05 8:04 pm | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 45,000 | $24.08 | $1,083,718 | 249,866 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-07-14 Option Award | 2023-07-17 5:28 pm | N/A 2033-07-14 | PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2023-05-26 Option Award | 2023-07-12 6:45 pm | N/A 2033-05-26 | RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director | 55,000 | $0 | 73,750 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 4:15 pm | N/A 2032-06-28 | PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2022-05-20 Option Award | 2022-05-23 5:50 pm | N/A 2032-05-20 | RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director | 41,250 | $0 | 41,250 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 4:33 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 45,518 | $0 | 160,214 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-17 4:22 pm | N/A 2031-12-16 | RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-03-11 Gift | 2021-11-22 4:03 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 7,500 | $0 | 114,696 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-17 7:09 pm | N/A 2031-06-17 | PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director | 9,000 | $0 | 20,764 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-02 9:47 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 33,189 | $0 | 131,688 (Direct) | View |
| 2021-05-06 Exercise | 2021-05-07 6:28 pm | N/A 2025-08-31 | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 20,416 | $0 | 149,034 (Direct) | View |
| 2021-05-06 Exercise | 2021-05-07 6:28 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 20,416 | $10.66 | 149,034 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-05 8:04 pm | N/A 2025-08-31 | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 45,000 | $0 | 249,866 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-05 8:04 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 45,000 | $10.66 | 249,866 (Direct) | View |
| 2021-03-01 Exercise | 2021-03-03 8:39 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 23,812 | $0 | 325,782 (Direct) | View |
| 2021-03-02 Tax Withholding | 2021-03-03 8:39 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,906 | $23.25 | 325,782 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 8:39 pm | N/A 2031-02-28 | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 127,900 | $0 | 325,782 (Direct) | View |
| 2021-03-01 Tax Withholding | 2021-03-03 8:39 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 4,934 | $24.06 | 325,782 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-03 5:26 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 3,875 | $0 | 130,521 (Direct) | View |
| 2021-02-01 Tax Withholding | 2021-02-03 5:26 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,318 | $21.35 | 130,521 (Direct) | View |
| 2020-12-15 Tax Withholding | 2020-12-17 5:06 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 498 | $4.59 | 124,089 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 5:06 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,734 | $0 | 124,089 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-25 6:38 pm | N/A 2030-06-23 | PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director | 3,033 | $0 | 3,033 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:42 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 33,188 | $0 | 156,042 (Direct) | View |
| 2020-06-01 Tax Withholding | 2020-06-03 4:42 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 9,534 | $1.32 | 156,042 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:22 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 17,175 | $0 | 336,580 (Direct) | View |
| 2020-03-02 Tax Withholding | 2020-03-04 4:22 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 4,779 | $1.26 | 336,580 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:22 pm | N/A 2030-03-01 | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 185,856 | $0 | 336,580 (Direct) | View |
| 2020-02-21 Option Award | 2020-02-24 4:30 pm | N/A 2030-02-21 | PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2020-02-03 Exercise | 2020-02-04 7:11 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 3,875 | $0 | 94,553 (Direct) | View |
| 2020-02-03 Tax Withholding | 2020-02-04 7:11 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,318 | $1.28 | 94,553 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:17 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,075 | $0 | 84,246 (Direct) | View |
| 2019-12-18 Tax Withholding | 2019-12-20 4:17 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 277 | $1.81 | 84,246 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 11:00 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,733 | $0 | 85,182 (Direct) | View |
| 2019-12-16 Tax Withholding | 2019-12-18 11:00 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 497 | $1.8 | 85,182 (Direct) | View |